Remnant cholesterol, vascular risk, and prevention of atherosclerosis Xavier Pintó; Marta Fanlo; Virginia Esteve; Jesús Millán;

Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;

Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors Jose Seijas-Amigo; Mónica Gayoso-Rey; María José Mauriz-Montero; Pedro Suarez-Artime; Antonia Casas-Martinez; María Dominguez-Guerra; Lara Gonzalez-Freire; Ana Estany-Gestal; Alberto Codero-Fort; Moisés Rodriguez-Mañero; Jose Ramón Gonzalez-Juanatey;